AYMROXA
Live / Allowed — First extension granted (statement of use) (as of 05 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Sept 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98747397
- Mark type
- Word mark
- Filed
- 12 Sept 2024
- Published for opposition
- 22 Jul 2025
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of the gastrointestinal disorders; Pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic dermatitis, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of asthma and other breathing disorders
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 16 Sept 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 16 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2026 — SOU EXTENSION 1 GRANTED
- 05 Mar 2026 — SOU EXTENSION 1 FILED
- 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jul 2025 — PUBLISHED FOR OPPOSITION
- 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED